Researchers at the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome have identified significant alterations in liver metabolism, including elevated bile acid levels, in individuals with Down syndrome. The study, published in Cell Reports, indicates that these metabolic changes may be influenced by dietary fat intake.
Key Findings
The research highlights a unique form of liver dysfunction in individuals with Down syndrome, a condition whose prevalence in this population was not previously well understood.
Human Plasma Analysis
Multiomic analysis of plasma samples collected from over 400 participants in the Human Trisome Project consistently revealed elevated bile acid levels across the lifespan of individuals with Down syndrome. These elevated levels were observed irrespective of body mass index (BMI) or co-occurring health conditions. Bile acids, produced from cholesterol in the liver, are essential for fat digestion and function as signaling molecules that regulate metabolism and inflammation.
Cellular-Level Observations
Hepatocytes (liver cells) derived from induced pluripotent stem cells donated by individuals with Down syndrome exhibited intrinsic metabolic dysfunction. This dysfunction included altered bile acid production and abnormally high fat storage, suggesting a genetic basis for the observed liver abnormalities.
Animal Model Validation
Further research utilizing the Dp16 mouse model, which shares many genetic features with Down syndrome, displayed notable liver abnormalities. These included inflammation, fibrosis, and a ductular reaction. Metabolomic analysis in these mice confirmed elevated bile acids, consistent with human observations. Gene expression profiling also indicated widespread disruptions in metabolic and inflammatory signaling pathways.
Dietary Influence on Liver Health
The study identified a significant role for dietary fat intake in influencing liver outcomes within the Dp16 mouse model:
- A high-fat diet exacerbated liver injury and led to steatosis, a form of liver disease.
- Conversely, a low-fat diet mitigated these adverse effects.
Kelly Sullivan, Senior Author and Associate Professor of Pediatrics, noted that Down syndrome profoundly impacts hepatic metabolism and that dietary fat intake can influence these effects in mouse models.
Implications and Future Research
This research provides comprehensive evidence of liver dysfunction in Down syndrome, emphasizing the potential importance of early monitoring and dietary strategies to manage associated risks. Lead author Lauren Dunn highlighted that these findings suggest dietary modification could improve liver and overall health for individuals with Down syndrome.
The research team plans to explore clinical interventions, including low-fat diets and lifestyle modifications, to determine their specific impact on liver health in individuals with Down syndrome.